Guide; revised 15 June 2010
Federal Bureau of Prisons
Clinical Practice Guidelines
January 1010
Reprinted from Australian Family Physician Vol. 39, No. 10, october 2010
UNAIDS/99.31E (English original, June 1999)
1st revision, April 2000
Reference book specifying the principles of intervention for all food security activities, from initial assessment to programme implementation.
Joint Action for Results
UNAIDS Outcome Framework: Business Case 2009–2011
Clinical Infectious Diseases 2010; 50:291–322
Journal of Tuberculosis Research, 2017, 5, 189-200
Background: In Benin, little is known about the influence of both gender and
HIV-status on diagnostic patterns and treatment outcomes of Tuberculosis
(TB) patients. Objective: To assess whether differences in gender and HIV
status affect diagn...ostic patterns and treatment outcomes of TB patients. Methods:
Retrospective cohort study of patients registered in 2013 and 2014 in
the three largest TB Basic Management Units in south Benin. Results: Of 2694
registered TB patients, 1700 (63.1%) were male. Case notification rates were
higher in males compared with females (96 vs 53/100,000 inhabitants). The
male to female ratio was 1:1 in HIV positive patients, but was 2:1 among HIV
negative cases. In HIV-positive patients, there were no differences in TB types
between men and women. In HIV-negative patients, there were significantly
higher proportions of females with clinically diagnosed pulmonary TB (p =
0.04) and extrapulmonary TB (p < 0.001). Retreatment TB was 4.65 times
higher amongst males compared with females. For New bacteriologically confirmed
pulmonary TB, no differences were observed in treatment outcomes
between genders in the HIV positive group; but significantly more unfavorable
outcomes were reported among HIV negative males, with higher rates of
failure (p < 0.001) and loss-to-follow up (p = 0.02). Conclusion: The study
has shown that overall TB notification rates were higher in males than in females
in south Benin, with more females co-infected with HIV. Unfavorable outcomes were more common in HIV-negative males.
more
В кратких клинических рекомендациях представлен перечень наиболее актуальных сведений о новой коронавирусной инфекции COVID-19. Он разработан рабочей группой, созда...нной при губернаторе Санкт-Петербурга, в состав которой вошли эксперты — акушеры-гинекологи, анестезиологи-реаниматологи, клинические фармакологи, кардиологи, организаторы здравоохранения, в качестве информационного ресурса для специалистов, работающих в сфере охраны материнства и детства.
Краткие клинические рекомендации предназначены врачам — акушерам-гинекологам, анестезиологам-реаниматологам, врачам скорой медицинской помощи и другим специалистам, работающим в области оказания медицинской помощи беременным, роженицам и родильницам в Санкт-Петербурге и Северо-Западном федеральном округе, а также клиническим ординаторам.
more
sthma prevalence is increasing worldwide, and surveys indicate that most patients in developed and developing countries, including South Africa, do not receive optimal care and are therefore not well controlled. Standard management guidelines adapted to in-country realities are important to support ...optimal care. The South African Thoracic Society (SATS) first published a guideline for the management of chronic persistent asthma in 1992, which has subsequently been revised several times.
The main aim of the present document was to revise and update SATS’ statement on the suggested management of chronic asthma, based on the need to promote optimal care and control of asthma, together with the incorporation of new concepts and drug developments. This revised document reinforces optimal care and incorporates the following primary objectives to achieve the recent advances in asthma care:
• continued emphasis on the use of inhaled corticosteroids (ICS) as the foundation of asthma treatment
• to reduce the reliance on short-acting beta-2 agonist (SABA) monotherapy for asthma symptoms
• to incorporate the evidence and strategy for the use of the combination of an ICS and formoterol for acute symptom relief (instead of a SABA)
• to incorporate the evidence and strategy for the use of as-needed ICS-long-acting beta agonists (LABA) for patients with infrequent symptoms or ‘mild’ asthma
• to incorporate the evidence and strategy for the use of a long-acting muscarinic antagonist (LAMA) in combination with ICS-LABA; and
• to incorporate the evidence and strategy for the use of and management with a biologic therapy in severe asthma.
more